ONCS(Delisted)
OncoSec MedicalยทNASDAQ
--
--(--)
ONCS Profile
Oncosec Medical Incorporated
A biotechnology company focused on developing intratumoral immunotherapies
820 Bear Tavern Road, Ewing, NJ 08628-1021
--
Oncosec Medical Incorporated was incorporated on February 8, 2008 under the laws of the State of Nevada. The Company is a late-stage immuno-oncology company focused on the design, development and commercialization of innovative, proprietary, intra-tumor DNA-based therapies to stimulate and enhance the anti-tumor immune response for the treatment of cancer. Their core technology platform, ImmunoPulse, is a drug device treatment model platform consisting of a proprietary intra-tumor electroporation (EP) delivery device (OMS EP device) and a proprietary DNA plasmid delivery and application method that triggers instantaneous expression of target proteins in cells. The OMS EP device is designed to deliver plasmid DNA-encoded drugs directly into solid tumors and promote immune responses against cancer.
